世界の急性間欠性ポルフィリン症（AIP）市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Acute Intermittent Porphyria Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z0058 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥553,800 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥830,700 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,107,600 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、急性間欠性ポルフィリン症（AIP）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ゴナドトロピン放出ホルモン類似体、予防的ヘマチン注入）、用途別市場規模（病院・クリニック、研究センター）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・急性間欠性ポルフィリン症（AIP）の市場動向 ・企業の競争状況、市場シェア ・急性間欠性ポルフィリン症（AIP）の種類別市場規模（ゴナドトロピン放出ホルモン類似体、予防的ヘマチン注入） ・急性間欠性ポルフィリン症（AIP）の用途別市場規模（病院・クリニック、研究センター） ・急性間欠性ポルフィリン症（AIP）の北米市場規模2016-2027（アメリカ、カナダ） ・急性間欠性ポルフィリン症（AIP）のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・急性間欠性ポルフィリン症（AIP）のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・急性間欠性ポルフィリン症（AIP）の中南米市場規模2016-2027（メキシコ、ブラジル） ・急性間欠性ポルフィリン症（AIP）の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Dahaner、Roche、Bio-Rad Laboratories、Siemens、ARKRAY、Sysmex Corporation、ACON Laboratories） ・結論

Acute intermittent porphyria (AIP) is a genetic metabolic disorder affecting the production of heme, the oxygen-binding prosthetic group of hemoglobin. It is characterized by a deficiency of the enzyme porphobilinogen deaminase.

Market Analysis and Insights: Global Acute Intermittent Porphyria Market
The global Acute Intermittent Porphyria market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Acute Intermittent Porphyria market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Acute Intermittent Porphyria market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Acute Intermittent Porphyria market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Acute Intermittent Porphyria market.

Global Acute Intermittent Porphyria Scope and Market Size
Acute Intermittent Porphyria market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Acute Intermittent Porphyria market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Gonadotropin-Releasing Hormone Analogues
Prophylactic Hematin Infusions

Segment by Application
Hospitals & Clinics
Research Centers

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Dahaner
Roche
Bio-Rad Laboratories
Siemens
ARKRAY
Sysmex Corporation
ACON Laboratories

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Acute Intermittent Porphyria Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Gonadotropin-Releasing Hormone Analogues
1.2.3 Prophylactic Hematin Infusions
1.3 Market by Application
1.3.1 Global Acute Intermittent Porphyria Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals & Clinics
1.3.3 Research Centers
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Acute Intermittent Porphyria Market Perspective (2016-2027)
2.2 Acute Intermittent Porphyria Growth Trends by Regions
2.2.1 Acute Intermittent Porphyria Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Acute Intermittent Porphyria Historic Market Share by Regions (2016-2021)
2.2.3 Acute Intermittent Porphyria Forecasted Market Size by Regions (2022-2027)
2.3 Acute Intermittent Porphyria Industry Dynamic
2.3.1 Acute Intermittent Porphyria Market Trends
2.3.2 Acute Intermittent Porphyria Market Drivers
2.3.3 Acute Intermittent Porphyria Market Challenges
2.3.4 Acute Intermittent Porphyria Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Acute Intermittent Porphyria Players by Revenue
3.1.1 Global Top Acute Intermittent Porphyria Players by Revenue (2016-2021)
3.1.2 Global Acute Intermittent Porphyria Revenue Market Share by Players (2016-2021)
3.2 Global Acute Intermittent Porphyria Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Acute Intermittent Porphyria Revenue
3.4 Global Acute Intermittent Porphyria Market Concentration Ratio
3.4.1 Global Acute Intermittent Porphyria Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Acute Intermittent Porphyria Revenue in 2020
3.5 Acute Intermittent Porphyria Key Players Head office and Area Served
3.6 Key Players Acute Intermittent Porphyria Product Solution and Service
3.7 Date of Enter into Acute Intermittent Porphyria Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Acute Intermittent Porphyria Breakdown Data by Type
4.1 Global Acute Intermittent Porphyria Historic Market Size by Type (2016-2021)
4.2 Global Acute Intermittent Porphyria Forecasted Market Size by Type (2022-2027)

5 Acute Intermittent Porphyria Breakdown Data by Application
5.1 Global Acute Intermittent Porphyria Historic Market Size by Application (2016-2021)
5.2 Global Acute Intermittent Porphyria Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Acute Intermittent Porphyria Market Size (2016-2027)
6.2 North America Acute Intermittent Porphyria Market Size by Type
6.2.1 North America Acute Intermittent Porphyria Market Size by Type (2016-2021)
6.2.2 North America Acute Intermittent Porphyria Market Size by Type (2022-2027)
6.2.3 North America Acute Intermittent Porphyria Market Size by Type (2016-2027)
6.3 North America Acute Intermittent Porphyria Market Size by Application
6.3.1 North America Acute Intermittent Porphyria Market Size by Application (2016-2021)
6.3.2 North America Acute Intermittent Porphyria Market Size by Application (2022-2027)
6.3.3 North America Acute Intermittent Porphyria Market Size by Application (2016-2027)
6.4 North America Acute Intermittent Porphyria Market Size by Country
6.4.1 North America Acute Intermittent Porphyria Market Size by Country (2016-2021)
6.4.2 North America Acute Intermittent Porphyria Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Acute Intermittent Porphyria Market Size (2016-2027)
7.2 Europe Acute Intermittent Porphyria Market Size by Type
7.2.1 Europe Acute Intermittent Porphyria Market Size by Type (2016-2021)
7.2.2 Europe Acute Intermittent Porphyria Market Size by Type (2022-2027)
7.2.3 Europe Acute Intermittent Porphyria Market Size by Type (2016-2027)
7.3 Europe Acute Intermittent Porphyria Market Size by Application
7.3.1 Europe Acute Intermittent Porphyria Market Size by Application (2016-2021)
7.3.2 Europe Acute Intermittent Porphyria Market Size by Application (2022-2027)
7.3.3 Europe Acute Intermittent Porphyria Market Size by Application (2016-2027)
7.4 Europe Acute Intermittent Porphyria Market Size by Country
7.4.1 Europe Acute Intermittent Porphyria Market Size by Country (2016-2021)
7.4.2 Europe Acute Intermittent Porphyria Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Acute Intermittent Porphyria Market Size (2016-2027)
8.2 Asia-Pacific Acute Intermittent Porphyria Market Size by Type
8.2.1 Asia-Pacific Acute Intermittent Porphyria Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Acute Intermittent Porphyria Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Acute Intermittent Porphyria Market Size by Type (2016-2027)
8.3 Asia-Pacific Acute Intermittent Porphyria Market Size by Application
8.3.1 Asia-Pacific Acute Intermittent Porphyria Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Acute Intermittent Porphyria Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Acute Intermittent Porphyria Market Size by Application (2016-2027)
8.4 Asia-Pacific Acute Intermittent Porphyria Market Size by Region
8.4.1 Asia-Pacific Acute Intermittent Porphyria Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Acute Intermittent Porphyria Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Acute Intermittent Porphyria Market Size (2016-2027)
9.2 Latin America Acute Intermittent Porphyria Market Size by Type
9.2.1 Latin America Acute Intermittent Porphyria Market Size by Type (2016-2021)
9.2.2 Latin America Acute Intermittent Porphyria Market Size by Type (2022-2027)
9.2.3 Latin America Acute Intermittent Porphyria Market Size by Type (2016-2027)
9.3 Latin America Acute Intermittent Porphyria Market Size by Application
9.3.1 Latin America Acute Intermittent Porphyria Market Size by Application (2016-2021)
9.3.2 Latin America Acute Intermittent Porphyria Market Size by Application (2022-2027)
9.3.3 Latin America Acute Intermittent Porphyria Market Size by Application (2016-2027)
9.4 Latin America Acute Intermittent Porphyria Market Size by Country
9.4.1 Latin America Acute Intermittent Porphyria Market Size by Country (2016-2021)
9.4.2 Latin America Acute Intermittent Porphyria Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Acute Intermittent Porphyria Market Size (2016-2027)
10.2 Middle East & Africa Acute Intermittent Porphyria Market Size by Type
10.2.1 Middle East & Africa Acute Intermittent Porphyria Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Acute Intermittent Porphyria Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Acute Intermittent Porphyria Market Size by Type (2016-2027)
10.3 Middle East & Africa Acute Intermittent Porphyria Market Size by Application
10.3.1 Middle East & Africa Acute Intermittent Porphyria Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Acute Intermittent Porphyria Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Acute Intermittent Porphyria Market Size by Application (2016-2027)
10.4 Middle East & Africa Acute Intermittent Porphyria Market Size by Country
10.4.1 Middle East & Africa Acute Intermittent Porphyria Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Acute Intermittent Porphyria Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Dahaner
11.1.1 Dahaner Company Details
11.1.2 Dahaner Business Overview
11.1.3 Dahaner Acute Intermittent Porphyria Introduction
11.1.4 Dahaner Revenue in Acute Intermittent Porphyria Business (2016-2021)
11.1.5 Dahaner Recent Development
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche Acute Intermittent Porphyria Introduction
11.2.4 Roche Revenue in Acute Intermittent Porphyria Business (2016-2021)
11.2.5 Roche Recent Development
11.3 Bio-Rad Laboratories
11.3.1 Bio-Rad Laboratories Company Details
11.3.2 Bio-Rad Laboratories Business Overview
11.3.3 Bio-Rad Laboratories Acute Intermittent Porphyria Introduction
11.3.4 Bio-Rad Laboratories Revenue in Acute Intermittent Porphyria Business (2016-2021)
11.3.5 Bio-Rad Laboratories Recent Development
11.4 Siemens
11.4.1 Siemens Company Details
11.4.2 Siemens Business Overview
11.4.3 Siemens Acute Intermittent Porphyria Introduction
11.4.4 Siemens Revenue in Acute Intermittent Porphyria Business (2016-2021)
11.4.5 Siemens Recent Development
11.5 ARKRAY
11.5.1 ARKRAY Company Details
11.5.2 ARKRAY Business Overview
11.5.3 ARKRAY Acute Intermittent Porphyria Introduction
11.5.4 ARKRAY Revenue in Acute Intermittent Porphyria Business (2016-2021)
11.5.5 ARKRAY Recent Development
11.6 Sysmex Corporation
11.6.1 Sysmex Corporation Company Details
11.6.2 Sysmex Corporation Business Overview
11.6.3 Sysmex Corporation Acute Intermittent Porphyria Introduction
11.6.4 Sysmex Corporation Revenue in Acute Intermittent Porphyria Business (2016-2021)
11.6.5 Sysmex Corporation Recent Development
11.7 ACON Laboratories
11.7.1 ACON Laboratories Company Details
11.7.2 ACON Laboratories Business Overview
11.7.3 ACON Laboratories Acute Intermittent Porphyria Introduction
11.7.4 ACON Laboratories Revenue in Acute Intermittent Porphyria Business (2016-2021)
11.7.5 ACON Laboratories Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Acute Intermittent Porphyria Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Gonadotropin-Releasing Hormone Analogues
Table 3. Key Players of Prophylactic Hematin Infusions
Table 4. Global Acute Intermittent Porphyria Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Acute Intermittent Porphyria Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Acute Intermittent Porphyria Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Acute Intermittent Porphyria Market Share by Regions (2016-2021)
Table 8. Global Acute Intermittent Porphyria Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Acute Intermittent Porphyria Market Share by Regions (2022-2027)
Table 10. Acute Intermittent Porphyria Market Trends
Table 11. Acute Intermittent Porphyria Market Drivers
Table 12. Acute Intermittent Porphyria Market Challenges
Table 13. Acute Intermittent Porphyria Market Restraints
Table 14. Global Acute Intermittent Porphyria Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Acute Intermittent Porphyria Market Share by Players (2016-2021)
Table 16. Global Top Acute Intermittent Porphyria Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Intermittent Porphyria as of 2020)
Table 17. Ranking of Global Top Acute Intermittent Porphyria Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Acute Intermittent Porphyria Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Acute Intermittent Porphyria Product Solution and Service
Table 21. Date of Enter into Acute Intermittent Porphyria Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Acute Intermittent Porphyria Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Acute Intermittent Porphyria Revenue Market Share by Type (2016-2021)
Table 25. Global Acute Intermittent Porphyria Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Acute Intermittent Porphyria Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Acute Intermittent Porphyria Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Acute Intermittent Porphyria Revenue Market Share by Application (2016-2021)
Table 29. Global Acute Intermittent Porphyria Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Acute Intermittent Porphyria Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Acute Intermittent Porphyria Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Acute Intermittent Porphyria Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Acute Intermittent Porphyria Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Acute Intermittent Porphyria Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Acute Intermittent Porphyria Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Acute Intermittent Porphyria Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Acute Intermittent Porphyria Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Acute Intermittent Porphyria Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Acute Intermittent Porphyria Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Acute Intermittent Porphyria Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Acute Intermittent Porphyria Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Acute Intermittent Porphyria Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Acute Intermittent Porphyria Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Acute Intermittent Porphyria Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Acute Intermittent Porphyria Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Acute Intermittent Porphyria Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Acute Intermittent Porphyria Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Acute Intermittent Porphyria Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Acute Intermittent Porphyria Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Acute Intermittent Porphyria Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Acute Intermittent Porphyria Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Acute Intermittent Porphyria Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Acute Intermittent Porphyria Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Acute Intermittent Porphyria Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Acute Intermittent Porphyria Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Acute Intermittent Porphyria Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Acute Intermittent Porphyria Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Acute Intermittent Porphyria Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Acute Intermittent Porphyria Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Acute Intermittent Porphyria Market Size by Country (2022-2027) & (US$ Million)
Table 61. Dahaner Company Details
Table 62. Dahaner Business Overview
Table 63. Dahaner Acute Intermittent Porphyria Product
Table 64. Dahaner Revenue in Acute Intermittent Porphyria Business (2016-2021) & (US$ Million)
Table 65. Dahaner Recent Development
Table 66. Roche Company Details
Table 67. Roche Business Overview
Table 68. Roche Acute Intermittent Porphyria Product
Table 69. Roche Revenue in Acute Intermittent Porphyria Business (2016-2021) & (US$ Million)
Table 70. Roche Recent Development
Table 71. Bio-Rad Laboratories Company Details
Table 72. Bio-Rad Laboratories Business Overview
Table 73. Bio-Rad Laboratories Acute Intermittent Porphyria Product
Table 74. Bio-Rad Laboratories Revenue in Acute Intermittent Porphyria Business (2016-2021) & (US$ Million)
Table 75. Bio-Rad Laboratories Recent Development
Table 76. Siemens Company Details
Table 77. Siemens Business Overview
Table 78. Siemens Acute Intermittent Porphyria Product
Table 79. Siemens Revenue in Acute Intermittent Porphyria Business (2016-2021) & (US$ Million)
Table 80. Siemens Recent Development
Table 81. ARKRAY Company Details
Table 82. ARKRAY Business Overview
Table 83. ARKRAY Acute Intermittent Porphyria Product
Table 84. ARKRAY Revenue in Acute Intermittent Porphyria Business (2016-2021) & (US$ Million)
Table 85. ARKRAY Recent Development
Table 86. Sysmex Corporation Company Details
Table 87. Sysmex Corporation Business Overview
Table 88. Sysmex Corporation Acute Intermittent Porphyria Product
Table 89. Sysmex Corporation Revenue in Acute Intermittent Porphyria Business (2016-2021) & (US$ Million)
Table 90. Sysmex Corporation Recent Development
Table 91. ACON Laboratories Company Details
Table 92. ACON Laboratories Business Overview
Table 93. ACON Laboratories Acute Intermittent Porphyria Product
Table 94. ACON Laboratories Revenue in Acute Intermittent Porphyria Business (2016-2021) & (US$ Million)
Table 95. ACON Laboratories Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Acute Intermittent Porphyria Market Share by Type: 2020 VS 2027
Figure 2. Gonadotropin-Releasing Hormone Analogues Features
Figure 3. Prophylactic Hematin Infusions Features
Figure 4. Global Acute Intermittent Porphyria Market Share by Application: 2020 VS 2027
Figure 5. Hospitals & Clinics Case Studies
Figure 6. Research Centers Case Studies
Figure 7. Acute Intermittent Porphyria Report Years Considered
Figure 8. Global Acute Intermittent Porphyria Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 9. Global Acute Intermittent Porphyria Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Acute Intermittent Porphyria Market Share by Regions: 2020 VS 2027
Figure 11. Global Acute Intermittent Porphyria Market Share by Regions (2022-2027)
Figure 12. Global Acute Intermittent Porphyria Market Share by Players in 2020
Figure 13. Global Top Acute Intermittent Porphyria Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Intermittent Porphyria as of 2020
Figure 14. The Top 10 and 5 Players Market Share by Acute Intermittent Porphyria Revenue in 2020
Figure 15. Global Acute Intermittent Porphyria Revenue Market Share by Type (2016-2021)
Figure 16. Global Acute Intermittent Porphyria Revenue Market Share by Type (2022-2027)
Figure 17. North America Acute Intermittent Porphyria Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 18. North America Acute Intermittent Porphyria Market Share by Type (2016-2027)
Figure 19. North America Acute Intermittent Porphyria Market Share by Application (2016-2027)
Figure 20. North America Acute Intermittent Porphyria Market Share by Country (2016-2027)
Figure 21. United States Acute Intermittent Porphyria Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. Canada Acute Intermittent Porphyria Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Europe Acute Intermittent Porphyria Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Acute Intermittent Porphyria Market Share by Type (2016-2027)
Figure 25. Europe Acute Intermittent Porphyria Market Share by Application (2016-2027)
Figure 26. Europe Acute Intermittent Porphyria Market Share by Country (2016-2027)
Figure 27. Germany Acute Intermittent Porphyria Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. France Acute Intermittent Porphyria Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. U.K. Acute Intermittent Porphyria Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Italy Acute Intermittent Porphyria Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Russia Acute Intermittent Porphyria Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Nordic Acute Intermittent Porphyria Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Asia-Pacific Acute Intermittent Porphyria Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Acute Intermittent Porphyria Market Share by Type (2016-2027)
Figure 35. Asia-Pacific Acute Intermittent Porphyria Market Share by Application (2016-2027)
Figure 36. Asia-Pacific Acute Intermittent Porphyria Market Share by Region (2016-2027)
Figure 37. China Acute Intermittent Porphyria Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Japan Acute Intermittent Porphyria Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. South Korea Acute Intermittent Porphyria Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Southeast Asia Acute Intermittent Porphyria Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. India Acute Intermittent Porphyria Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Australia Acute Intermittent Porphyria Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Latin America Acute Intermittent Porphyria Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Acute Intermittent Porphyria Market Share by Type (2016-2027)
Figure 45. Latin America Acute Intermittent Porphyria Market Share by Application (2016-2027)
Figure 46. Latin America Acute Intermittent Porphyria Market Share by Country (2016-2027)
Figure 47. Mexico Acute Intermittent Porphyria Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Brazil Acute Intermittent Porphyria Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Middle East & Africa Acute Intermittent Porphyria Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Acute Intermittent Porphyria Market Share by Type (2016-2027)
Figure 51. Middle East & Africa Acute Intermittent Porphyria Market Share by Application (2016-2027)
Figure 52. Middle East & Africa Acute Intermittent Porphyria Market Share by Country (2016-2027)
Figure 53. Turkey Acute Intermittent Porphyria Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Saudi Arabia Acute Intermittent Porphyria Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. UAE Acute Intermittent Porphyria Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Dahaner Revenue Growth Rate in Acute Intermittent Porphyria Business (2016-2021)
Figure 57. Roche Revenue Growth Rate in Acute Intermittent Porphyria Business (2016-2021)
Figure 58. Bio-Rad Laboratories Revenue Growth Rate in Acute Intermittent Porphyria Business (2016-2021)
Figure 59. Siemens Revenue Growth Rate in Acute Intermittent Porphyria Business (2016-2021)
Figure 60. ARKRAY Revenue Growth Rate in Acute Intermittent Porphyria Business (2016-2021)
Figure 61. Sysmex Corporation Revenue Growth Rate in Acute Intermittent Porphyria Business (2016-2021)
Figure 62. ACON Laboratories Revenue Growth Rate in Acute Intermittent Porphyria Business (2016-2021)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed

---